These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2449487)

  • 21. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs.
    Tasaka K; Mio M; Okamoto M
    Ann Allergy; 1986 Jun; 56(6):464-9. PubMed ID: 2424349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiallergic effects of major metabolites of astemizole in rats and guinea pigs.
    Kamei C; Mio M; Izushi K; Kitazumi K; Tsujimoto S; Fujisawa K; Adachi Y; Tasaka K
    Arzneimittelforschung; 1991 Sep; 41(9):932-6. PubMed ID: 1724600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease.
    Togias AG; Proud D; Kagey-Sobotka A; Freidhoff L; Lichtenstein LM; Naclerio RM
    Ann Allergy; 1989 Nov; 63(5):465-9. PubMed ID: 2573301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
    Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
    Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mediator and cellular basis of the allergic response.
    Church MM; Lai C; Beasley R; Featherstone RL; Holgate ST
    Allergy; 1988; 43 Suppl 8():26-9. PubMed ID: 2462372
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibitory effect of mast cell-mediated immediate-type allergic reactions by sulfapyridine.
    Kim HM; An NH; Yi BH; Chae HJ; Kim HR; Moon SJ; Kim JJ; Park ST; Baek SH
    Immunopharmacol Immunotoxicol; 2000 May; 22(2):253-66. PubMed ID: 10952030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunopharmacological studies on TBX, a new antiallergic drug (2). Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats.
    Yanagihara Y; Kasai H; Shida T
    Jpn J Pharmacol; 1988 Sep; 48(1):103-12. PubMed ID: 2462073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
    García G; DeMora F; Ferrer L; Puigdemont A
    Am J Vet Res; 1997 Mar; 58(3):293-7. PubMed ID: 9055977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of immunological histamine release from guinea pig lungs and other organs by mepyramine, ketotifen, and picumast in vivo.
    Sekardi L; Friedberg KD
    Arzneimittelforschung; 1989 Oct; 39(10A):1331-5. PubMed ID: 2483312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals.
    Ishii K; Yakuo I; Seto Y; Kita A; Nakamura H; Nishikawa Y
    Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). II. A lack of correlation between inhibition of mediator release and levels of cyclic AMP.
    Coutts SM; Khandwala A; Weinryb I
    Int Arch Allergy Appl Immunol; 1983; 70(4):303-10. PubMed ID: 6186609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of oxatomide on intracellular Ca mobilization, Ca uptake and histamine release, using rat peritoneal mast cells.
    Tasaka K; Akagi M; Mio M; Miyoshi K; Nakaya N
    Int Arch Allergy Appl Immunol; 1987; 83(4):348-53. PubMed ID: 2440814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils.
    Nabe M; Agrawal DK; Sarmiento EU; Townley RG
    Clin Exp Allergy; 1989 Sep; 19(5):515-20. PubMed ID: 2477125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic characterization of the antiallergic activity of SK&F 78729-A.
    Chakrin LW; Krell RD
    J Pharmacol Exp Ther; 1978 Dec; 207(3):756-66. PubMed ID: 83359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacological study of ebastine, a novel histamine H1-receptor antagonist].
    Yakuo I; Ishii K; Seto Y; Imano K; Takeyama K; Nakamura H; Karasawa T
    Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):121-35. PubMed ID: 7511558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of emedastine difumarate on histamine release.
    Saito T; Hagihara A; Igarashi N; Matsuda N; Yamashita A; Ito K; Mio M; Tasaka K
    Jpn J Pharmacol; 1993 Jun; 62(2):137-43. PubMed ID: 7690432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CR 2039, a new bis-(1H-tetrazol-5-yl)phenylbenzamide derivative with potential for the topical treatment of asthma.
    Revel L; Colombo S; Ferrari F; Folco G; Rovati LC; Makovec F
    Eur J Pharmacol; 1992 Dec; 229(1):45-53. PubMed ID: 1282105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symposium on allergic lung disease. IV. Immunologic mechanisms for release of chemical mediators of anaphylaxis from human lung tissue.
    Kaliner M
    Can Med Assoc J; 1974 Feb; 110(4):431 passim. PubMed ID: 4134081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of histamine-H1 receptor antagonism with terfenadine on concentration-related AMP-induced bronchoconstriction in asthma.
    Phillips GD; Polosa R; Holgate ST
    Clin Exp Allergy; 1989 Jul; 19(4):405-9. PubMed ID: 2569356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiallergic activity profile in vitro of RHC 2963 and related compounds.
    Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Youssefyeh RD
    Int J Immunopharmacol; 1983; 5(6):491-502. PubMed ID: 6198298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.